학술논문
Intravenous and oral ibandronate reduce the risk of skeletal-related events (SREs) in patients with breast cancer and bone metastases
Document Type
Abstract
Author
Source
In EJC Supplements 2004 2(3):138-138
Subject
Language
ISSN
1359-6349